Literature Recap: Commentaries
Posted in Papers / Editor's Picks / Commentaries / November 16-30, 2023
CGRP signalling in migraine: time to look downstream?
Posted on November 29, 2023
Posted in Papers / Commentaries / November 16-30, 2023
Combining onabotulinumtoxin A with a CGRP antagonist for chronic migraine prophylaxis: where do we stand?
Posted on November 16, 2023
Posted in Papers / Commentaries / November 16-30, 2023
Serotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experience
Posted on November 16, 2023
Posted in Papers / Commentaries / November 1-15, 2023
Gepants in the acute management of migraine
Posted on November 9, 2023
Posted in Papers / Commentaries / November 1-15, 2023
Unmet Needs in the Acute Treatment of Migraine
Posted on November 9, 2023
Posted in Papers / Commentaries / November 1-15, 2023
Refractory migraine: a cerebrovascular disease?
Posted on November 8, 2023
Posted in Papers / Commentaries / October 16-31, 2023
Understanding the links between airborne hazards and headache disorders
Posted on October 26, 2023
Posted in Papers / Commentaries / October 16-31, 2023
Editorial: Subtypes of typical migraine with aura: exploring markers for subtype classification and treatment response
Posted on October 25, 2023
Posted in Papers / Commentaries / October 16-31, 2023
Hypermobility spectrum disorders and migraine in adolescents
Posted on October 24, 2023